Published • loading... • Updated
Scientists’ New Gum Stops Spread of Flu and Herpes
Clinical-grade bean gum reduced herpes and influenza viral loads by over 95%, offering a novel approach to limit transmission where vaccines are limited or unavailable.
- University of Pennsylvania researchers led by Professor Henry Daniell tested a lablab-bean chewing gum that neutralized HSV-1, HSV-2 and influenza A strains H1N1 and H3N2 with effective and consistent FRIL release.
- Seeking transmission controls, the team focused on the oral cavity because viruses spread more efficiently through the mouth than the nose, a major global challenge amid low influenza vaccination rates and no HSV vaccine.
- A two-gram gum tablet containing 40 milligrams of bean material showed a viral load reduction of more than 95%, and researchers prepared the gum as a clinical-grade drug product and found it safe.
- Daniell said the findings `augur well` for human clinical studies, and the team plans to test bean powder in bird feed to combat bird flu, having neutralized H5N1 and H7N9.
- HSV-1 infects more than two-thirds globally, causing infectious blindness, and researchers described a broad-spectrum antiviral protein in a natural food product that neutralizes human and avian flu.
Insights by Ground AI
28 Articles
28 Articles
An antiviral chewing gum to reduce influenza and herpes simplex virus transmission
Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral chewing gum to substantially reduce viral loads of two herpes simplex viruses and two influenza A strains in experimental models.
·United States
Read Full ArticleCoverage Details
Total News Sources28
Leaning Left5Leaning Right3Center6Last UpdatedBias Distribution43% Center
Bias Distribution
- 43% of the sources are Center
43% Center
L 36%
C 43%
R 21%
Factuality
To view factuality data please Upgrade to Premium

















